Corticosteroids for ocular toxoplasmosis
Referencias
Additional references
Anderson S. Toxoplasma gondii. In: Mandell Gl, Douglas RG, Bennet JE editor(s). Principles and practice of infectious diseases. New York: John Wiley & Sons, 1979.
Bloch‐Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. American Journal of Ophthalmology 1987;103(2):234‐5.
Fine SL, Owens SL, Haller JA, Knox DL, Patz A. Choroidal neovascularization as a late complication of ocular toxoplasmosis. American Journal of Ophthalmology 1981;91(3):318‐22.
Folk JC, Lobers LA. Presumed toxoplasmis papillitis. Ophthalmology 1984;91(1):64‐7.
Gilbert RE, Dunn DT, Lightman S, Murray PI, Pavesio CE, Gormley PD, et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiology and Infection 1999;123(2):283‐9.
Gilbert RE, Harden M, Stanford MR. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database of Systematic Reviews 2002, Issue 1. [Art. No.: CD002218. DOI: 10.1002/14651858.CD002218]
Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6.
Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. American Journal of Ophthalmology 1959;47(5, part 2):155‐70.
Klaren VN, Kijlstra A. Toxoplasmosis, an overview with emphasis on ocular involvement. Ocular Immunology & Inflammation 2002;10(1):1‐26.
Lum F, Jones JL, Holland GN, Liesegang TJ. Survey of ophthalmologists about ocular toxoplasmosis. American Journal of Ophthalmology 2005;140(4):724‐7.
Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985;92(4):467‐71.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform metaanalyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.
